M. E. Lokhmatova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
M. E. Lokhmatova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
N. A. Karamjan
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
3 shared publications- Svetlana Mann
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Healthcare, Samora Machel Street, 1, GSP-7, Moscow 117198, Russia
3 shared publications - Evgeny Litvin
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
2 shared publications - M. V. Krasilnikova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
2 shared publications - Svetlana Plyasunova
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
2 shared publications - A. O. Koposova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
1 shared publication
Latest Publications
- Open Access
- 15 October 2022
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 21 (3) , 77-83
Rare unstable hemoglobin Hakkari in Russia: a case report and literature review
Here we report the first case of unstable hemoglobin Hakkari identified in Russia to our knowledge. It was diagnosed in a two-year-old Russian boy with severe transfusion-dependent anemia caused by a de novo mutation in the b-globin gene [b31(B13) Leu→Arg, HBB: c.95TG]. Routine diagnostic methods were not effective, and his diagnosis was not established until gene sequencing of the globin gene was performed. A comparative analysis of all known cases of unstable Hb Hakkari allows for the identification of similarities and differences in the clinical and laboratory course of the disease. The patient's parents gave their consent to the use of their child's data, including photographs, for research purposes and in publications.
- 15 October 2022
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 21 (3) , 77-83
Open AccessRare unstable hemoglobin Hakkari in Russia: a case report and literature review
Here we report the first case of unstable hemoglobin Hakkari identified in Russia to our knowledge. It was diagnosed in a two-year-old Russian boy with severe transfusion-dependent anemia caused by a de novo mutation in the b-globin gene [b31(B13) Leu→Arg, HBB: c.95TG]. Routine diagnostic methods were not effective, and his diagnosis was not established until gene sequencing of the globin gene was performed. A comparative analysis of all known cases of unstable Hb Hakkari allows for the identification of similarities and differences in the clinical and laboratory course of the disease. The patient's parents gave their consent to the use of their child's data, including photographs, for research purposes and in publications.
- Open Access
- 22 December 2021
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 20 (4) , 13-21
Unstable abnormal hemoglobins found in Russia in the past 10 years
From 2010 to 2020, we investigated 197 children with hemolytic anemia of unknown etiology at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. Fifty-four of them were found to have hemoglobinopathy caused by unstable abnormal hemoglobins: Hb Monroe/Kairouan, Hb Tacoma, Hb Köln/SanFrancisco, Hb Cheverly, Hb City of Hope, Hb Southampton/Casper, Hb M-Hyde Park/Akita/Milwaukee-2, Hb Buenos Aires/Bryn Mawr, Hb Louisville/Bucureşti, Hb Genova/Hyogo, Hb Roseau-Pointe a Pitre, Hb Bristol/Alesha, Hb Henri Mondor, Hb Knossos, Hb Leiden, Hb Little Venice, Hb Olmsted, Hb Sabine, Hb Showa-Yakushiji, Hb Terre Haute, Hb Tübingen, Hb Quin-Hai. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The patients' parents signed the informed consent for molecular genetic testing and gave their consent to the use of their children's data, including photographs, for research purposes and in publications.
- 22 December 2021
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 20 (4) , 13-21
Open AccessUnstable abnormal hemoglobins found in Russia in the past 10 years
From 2010 to 2020, we investigated 197 children with hemolytic anemia of unknown etiology at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. Fifty-four of them were found to have hemoglobinopathy caused by unstable abnormal hemoglobins: Hb Monroe/Kairouan, Hb Tacoma, Hb Köln/SanFrancisco, Hb Cheverly, Hb City of Hope, Hb Southampton/Casper, Hb M-Hyde Park/Akita/Milwaukee-2, Hb Buenos Aires/Bryn Mawr, Hb Louisville/Bucureşti, Hb Genova/Hyogo, Hb Roseau-Pointe a Pitre, Hb Bristol/Alesha, Hb Henri Mondor, Hb Knossos, Hb Leiden, Hb Little Venice, Hb Olmsted, Hb Sabine, Hb Showa-Yakushiji, Hb Terre Haute, Hb Tübingen, Hb Quin-Hai. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The patients' parents signed the informed consent for molecular genetic testing and gave their consent to the use of their children's data, including photographs, for research purposes and in publications.
- 28 May 2021
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 100 (3)
DIFFICULTIES IN VERIFYING THE CAUSES OF IRON-DEFICIENCY ANAEMIA REFRACTORY TO ADEQUATELY ADMINISTERED THERAPY WITH IRON SUPPLEMENTS
Diseases of the gastrointestinal tract (GIT) are one of the reasons for the development of iron deficiency anemia (IDA). The presence of gastroenterological pathology often leads to the refracterity of anemia to standard therapy, which necessitates timely diagnosis and adequate correction of background disease. A rare variant of anemia refractory to ferrotherapy is iron-refractory IDA (IRIDA), whose genesis contains an iron exchange disorder caused by a mutation in the TMPRSS6 gene. The article discusses the differential diagnostic spectrum of GIT diseases as potential causes of anemia, examines the pathogenetic mechanisms of IRIDA in a clinical trial, which required the elimination of a genetically deterministic iron exchange disorder at the diagnostic stage.
- 28 May 2021
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 100 (3)
DIFFICULTIES IN VERIFYING THE CAUSES OF IRON-DEFICIENCY ANAEMIA REFRACTORY TO ADEQUATELY ADMINISTERED THERAPY WITH IRON SUPPLEMENTS
Diseases of the gastrointestinal tract (GIT) are one of the reasons for the development of iron deficiency anemia (IDA). The presence of gastroenterological pathology often leads to the refracterity of anemia to standard therapy, which necessitates timely diagnosis and adequate correction of background disease. A rare variant of anemia refractory to ferrotherapy is iron-refractory IDA (IRIDA), whose genesis contains an iron exchange disorder caused by a mutation in the TMPRSS6 gene. The article discusses the differential diagnostic spectrum of GIT diseases as potential causes of anemia, examines the pathogenetic mechanisms of IRIDA in a clinical trial, which required the elimination of a genetically deterministic iron exchange disorder at the diagnostic stage.
- Open Access
- 8 September 2020
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 19 (3) , 73-76
Transfusion-dependent phenotype of thalassemia in case of combined carriage of globin genes abnormalities: a-globin gene triplikation and b-thalassemia
Thalassemia is a group of hereditary hemolytic anemias, caused by a quantitative violation of the globin chains synthesis. In adults, the main hemoglobin (HbA) consists of two a- and two b-chains. Normally, regulatory mechanisms maintain a balance between a- and non-a-globin chains in a 1:1 ratio. Mutations in the b-globin gene, leading to a quantitative disruption of the synthesis of b-globin chains, lead to the development of b-thalassemia. In such patients, the presence of concomitant breakdowns of a-globin genes can determine the variability of the clinical symptoms, both mitigating or increasing the severity of the manifestations of beta-thalassemia. The article describes two clinical cases of transfusion-dependent thalassemia with a rare genotype: aaaanti-3.7/aa and b-thalassemia. Parents gave their consent to use information about the child, including fotos, in the article.
- 8 September 2020
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 19 (3) , 73-76
Open AccessTransfusion-dependent phenotype of thalassemia in case of combined carriage of globin genes abnormalities: a-globin gene triplikation and b-thalassemia
Thalassemia is a group of hereditary hemolytic anemias, caused by a quantitative violation of the globin chains synthesis. In adults, the main hemoglobin (HbA) consists of two a- and two b-chains. Normally, regulatory mechanisms maintain a balance between a- and non-a-globin chains in a 1:1 ratio. Mutations in the b-globin gene, leading to a quantitative disruption of the synthesis of b-globin chains, lead to the development of b-thalassemia. In such patients, the presence of concomitant breakdowns of a-globin genes can determine the variability of the clinical symptoms, both mitigating or increasing the severity of the manifestations of beta-thalassemia. The article describes two clinical cases of transfusion-dependent thalassemia with a rare genotype: aaaanti-3.7/aa and b-thalassemia. Parents gave their consent to use information about the child, including fotos, in the article.
- Open Access
- 2 July 2020
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 19 (2) , 178-183
Hematopoietic stem cell transplantation in patients with transfusion-dependent β-thalassemia. Review article
Thalassemia is the most common form of hereditary anemia from the hemoglobinopathy group. The genetic disorder underlying thalassemia leads to impaired erythrocyte maturation, hemolysis, and the development of ineffective erythropoiesis with erythroid gland hyperplasia in the bone marrow and extramedullary. Regular blood transfusions and chelator therapy are standard therapy for patients with b-thalassemia. This method increases life expectancy, but does not improve its quality and does not cure the disease. Currently, allogeneic hematopoietic stem cell transplantation remains the only radical treatment for thalassemia. The paper discusses the historical aspects of the development of allogeneic hematopoietic stem cell transplantation in the context of transfusion-dependent form of b-thalassemia treatment.
- 2 July 2020
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 19 (2) , 178-183
Open AccessHematopoietic stem cell transplantation in patients with transfusion-dependent β-thalassemia. Review article
Thalassemia is the most common form of hereditary anemia from the hemoglobinopathy group. The genetic disorder underlying thalassemia leads to impaired erythrocyte maturation, hemolysis, and the development of ineffective erythropoiesis with erythroid gland hyperplasia in the bone marrow and extramedullary. Regular blood transfusions and chelator therapy are standard therapy for patients with b-thalassemia. This method increases life expectancy, but does not improve its quality and does not cure the disease. Currently, allogeneic hematopoietic stem cell transplantation remains the only radical treatment for thalassemia. The paper discusses the historical aspects of the development of allogeneic hematopoietic stem cell transplantation in the context of transfusion-dependent form of b-thalassemia treatment.
- Open Access
- 10 August 2017
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 16 (3) , 83-91
Inherited disorders of iron metabolism
The presented review provides information about genetic diseases associated with impaired iron metabolism, includes the main aspects of normal iron metabolism, the mechanisms of its disruption for each described pathology. The review also presents information about major clinical manifestation, changes in laboratory parameters and the principles of therapy.
- 10 August 2017
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 16 (3) , 83-91
Open AccessInherited disorders of iron metabolism
The presented review provides information about genetic diseases associated with impaired iron metabolism, includes the main aspects of normal iron metabolism, the mechanisms of its disruption for each described pathology. The review also presents information about major clinical manifestation, changes in laboratory parameters and the principles of therapy.
- 10 August 2017
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 16 (3)
The Peitz–Eggers' syndrome as the cause of iron deficiency anemia in a 5-year-old child: the diagnostic value of capsule enteroscopy
This clinical case demonstrates the diagnostic value of capsule endoscopy for the detection of polyposis of gastro-intestinal tract (Peutz–Jeghers syndrome). We report the case of a 5-year-old male presenting with a chronic iron refractory iron deficiency anemia. Multiple polyps of the stomach and small intestine with an erosive and hemorrhagic component were identified by the method of capsule endoscopy.
- 10 August 2017
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 16 (3)
The Peitz–Eggers' syndrome as the cause of iron deficiency anemia in a 5-year-old child: the diagnostic value of capsule enteroscopy
This clinical case demonstrates the diagnostic value of capsule endoscopy for the detection of polyposis of gastro-intestinal tract (Peutz–Jeghers syndrome). We report the case of a 5-year-old male presenting with a chronic iron refractory iron deficiency anemia. Multiple polyps of the stomach and small intestine with an erosive and hemorrhagic component were identified by the method of capsule endoscopy.